Use of @entity171 in XXXX and adolescents.

@entity3604 @entity1 @entity6017 @entity5442 @entity171 @entity11810 @entity5 @entity170 @entity4262 @entity79 @entity134 @entity6926 @entity1120 @entity729 @entity2742
The @entity171 are chemically simple compounds that have been used mainly for the treatment of @entity3604 and for hypercalcaemia. They have had relatively limited use in @entity1 . Their action is principally to interfere with the activity of osteoclasts by causing apoptosis. Their use in @entity1 has been for problems of soft tissue calcification (e.g. idiopathic @entity729 , @entity5442 ossificans progressiva and @entity6017 ), hypercalcaemia (e.g. caused by @entity5 , immobilisation or @entity2742 ), generalised @entity79 (e.g. @entity6926 , @entity11810 and @entity134 -induced @entity170 ) and localised @entity79 (e.g. @entity1120 and @entity4262 ). In general they cause few short-term side effects although the long-term side effects have yet to be determined, but are probably relatively unimportant. The @entity171 are likely to prove a useful addition to the armamentarium of treatment modalities for @entity79 in @entity1 .
